[1] Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes[J]. JAMA, 2005, 293(2): 217-228. [2] 张 妲, 关小宏.糖尿病足溃疡与炎症[J].中国老年学杂志, 2013, 33(2):493-495. [3] Bakker K, Apelqvist J, Schaper NC, et al. Practical guidelines on the management and prevention of the diabetic foot 2011[J]. Diabetes Metab Res Rev, 2012, 28(Suppl 1):225-231. [4] Wagner FW Jr. The dysvascular foot:a system of diagnosis and treatment[J]. Foot Ankle, 1981, 2(2):64-122. [5] 李秀钧, 邬云红.糖尿病是一种炎症性疾病[J].中华内分泌代谢杂志, 2003, 19(4):251-253. [6] Weigelt C, Rose B, Poschen U, et al.Immune mediators in patients with acute diabetic foot syndrome[J]. Diabetes Care, 2009, 32(8):1491-1496. [7] Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration[J]. Diabetes, 2012, 61(11):2937-2947. [8] 唐可京, 谢灿茂, 李幼姬.细胞间粘附分子-1和血管细胞间粘附分子-1的结构与功能[J].细胞与分子免疫学杂志, 2002, 18(2):193-195. [9] 徐茂锦, 邹大进, 叶江洪.高糖、晚期糖化终产物对微血管内皮细胞VCAM-1表达的影响[J].解放军医学杂志, 2002, 27(7):618-619. [10] 吴 煜, 熊 瑛, 崔 驰.FGF-2的非酶糖基化修饰及对糖尿病血管病变的影响[J].中外医疗, 2009, 28(23):14-15. [11] Xu J, Wu HF, Ang ES, et al. NF-kappa B modulators in osteolytic bone diseases[J].Cytokine Growth Factor Rev, 2009, 20(1):7-17. [12] Uccioli L, Sinistro A, Almerighi C, et al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot[J].Diabetes Care, 2010, 33(2):350-355. [13] 陈立立, 胡仁明.2型糖尿病发病的炎症机制[J].中华糖尿病杂志, 2012, 4(4):248-251. [14] 王伟灵, 赵延荣, 周丽霞, 等.糖尿病足坏疽患者血脂、凝血功能与踝肱指数的相关性分析[J].检验医学, 2010, 25(11):897-900. [15] Rattan R, Nayak D. High levels of plasma malondialdehyde, protein carbonyl, and fibrinogen have prognostic potential to predict poor outcomes in patient with diabetic foot wounds: a preliminary communication[J].Int J Low Extrem Wounds, 2008, 7(4):198-203. [16] 孙好杰, 王鹏华, 丁 敏, 等.糖尿病足截趾患者的转归——5年的随访研究[J].中华内分泌代谢杂志, 2012, 28(3):201-206. |